Effect of antiarrhythmic therapy with intravenous loading dose of amiodarone: Evidence for an altered response in diabetic patients

International Journal of Clinical Pharmacology Research

Volumn 18, Issue 3, 1998, Pages 109-120

  Iervasi, G ^a   Clerico, A ^a   Bonini, R ^a   Nannipieri, M ^a   Manfredi, C ^a   Sabatino, L ^a   Biagini, A ^a   Donato, L ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE;

ADULT; AGED; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CARDIOVERSION; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART RATE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; SINUS RHYTHM;

ADULT; AGED; AGED, 80 AND OVER; AMIODARONE; ANALYSIS OF VARIANCE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ATRIAL FLUTTER; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, TYPE 2; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC;

EID: 0031769154     PISSN: 02511649     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Gill J., Heel R.C., Fitton A. Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias. Drugs. 43, 69, 1992.
2. Naccarelli G.V., Jalal S. Intravenous amiodarone. Another option in the acute management of sustained ventricular tachyarrhythmias. Circulation, 92, 3154, 1995.
3. Singh B.N., Sarma J.S.M. Amiodarone and amiodarone derivatives. In: Singh B.N., Dzau V.J., Vanhoutte P.M., Woosley R.L. (Eds.). "Cardiovascular Pharmacology and Therapeutics." Churchill Livingstone Inc., New York, 1994, pp 689-709.
4. Woosley R.L. Antiarrhythmic drugs. In: Sciant R.C., Alexander R.W. (Eds.). "The Heart, Arteries and Veins", 8th edn. McGraw-Hill Inc., New York, London, 1994, pp 775-805.
5. Nora M., Zipes D. Empiric use of amiodarone and sotalol. Am J. Cardiol., 72, 62F, 1993
6. Zarembski D.G., Nolan P.E., Slack M.K., Caruso A.C. Empiric long-term amiodarone prophylaxis following myocardial infarction. Arch. Intern. Med., 153, 2661, 1993.
7. Burkart F., Pfisterer M., Kiowski W., Follath F., Burckhardt D. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: Basel Antiarrhythmic Study of Infarct Survival (BASIS). J. Am. Coll. Cardiol., 16, 1711, 1990.
8. Doval H.C., Nul D.R., Grancelli H.O., Perrone S.V., Bortman G.R., Curiel R. Randomised trial of low-dose amiodarone in severe congestive heart failure. Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiacaen Argentina (GESICA). Lancet, 344, 493, 1994.
9. Garguichevich J.J., Ramos J.L., Gambarte A., et al. Effect of amiodarone therapy on mortality in patients with left ventricular dysfunction and asymptomatic complex ventricular arrhythmias: Argentine Pilot Study of Sudden Death and Amiodarone (EPAMSA). Am. Heart J., 130, 494, 1995.
10. Scheinman M.M., Levine J.H., Cannom D.S., et al. Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group. Circulation, 92, 3264, 1995.
11. Singh S.N., Fletcher R.D., Fisher S.G., et al Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. N. Engl. J. Med., 333, 77, 1995.
12. Zehender M., Hohnloser S., Muller B., Meinertz T. Effects of amiodarone versus quinidine and verapamil in patients with chronic atrial fibrilation: results of a comparative study and a 2-year follow-up. J. Am. Coll. Cardiol., 19, 1054, 1992.
13. Kannel W.B., McGee D.L. Diabetes and cardiovascular disease: the Framingham Study. J.A.M.A., 241, 2035, 1979.
14. Zonszein J., Fein F.S., Sonnenblick E.H. The heart and endocrine disease. In: Sciant R.C., Alexander R.W. (Eds.). "The Heart, Arteries and Veins", 8th edn. McGraw-Hill Inc., New York, London, 1994, pp 1907-1920.
15. Nesto R.W, Zarich S.W, Jacoby R.M., Kamalesh M. Heart disease in diabetes. In: Kahn C.R., Weir G.C. (Eds.). "Joslin's Diabetes Mellitus", 13th edn. Lea & Febiger, Philadelphia, 1994, pp 836-852.
16. Fein F.S. Heart disease in diabetes. Cardiovasc. Rev. Rep., 3, 877, 1982.
17. Kahn J.K., Sisson J.C., Vinik A.I. QT interval prolongation and sudden cardiac death in diabetic autonomic neuropathy. J. Clin. Endocrinol. Metab., 64, 751, 1987.
18. Bellaverde R, Ferri M., Guarini L., et al. Prolonged QT period in diabetic autonomic neuropathy: a possible role in sudden cardiac death? Br. Heart J., 59, 379, 1988.
19. Schwartz A., Shen E., Morady F., Gillespie K., Scheinman M., Chatterjee K Hemodynamic effects of intravenous amiodarone in patients with depressed left ventricular function and recurrent ventricular tachycardia. Am. Heart J., 106, 848, 1983.
20. Kadish A.H., Chen R.F., Schmaltz S., Morady F. Magnitude and time course of ß-adrenergic antagonism during oral amiodarone therapy. J. Am. Coll. Cardiol., 16, 1240, 1990.
21. Du X.J., Esler M.D., Dart A.M. Sympatholytic action of intravenous amiodarone in the rat heart. Circulation, 91 (2): 462, 1995.
22. Mantredi C., Clerico A., Iervasi G., et al. Measurement of serum amiodarone and desethylamiodarone by HPLC: its usefulness in the follow-up of arrhythmic patients treated with amiodarone Int. J. Clin. Pharmacol., 15, 87, 1995.
23. Wellens H.J.J, Brugada P., Adollah H., Dassen W.R. A comparison of the electrophysiological effects of intravenous and oral amiodarone in the same patient. Circulation, 69, 120, 1984.
24. Lloyd-Mostyn R.N., Watkins P.J. Total cardiac denervation in diabetic autonomic neuropathy. Diabetes, 25, 748, 1976.
25. Ward J.D Diabetic neuropathy. In: Alberti K.G.M.M., DeFronzo R.A., Keen H., Zimmet P. (Eds.). "International Textbook of Diabetes Mellitus." John Wiley & Sons Ltd, Chichester, 1992, pp 1385-1414.
26. Mackay J.D., Page M., Cambridge McB., Watkins P.J. Diabetic autonomic neuropathy. Diabetologia, 18, 471, 1980.
27. Ewing D.J., Borsey D.Q., Travis P., Bellavere F., Neilson J.M.M., Clarke B.F. Abnormalities of ambulatory 24-hour heart rate in diabetes mellitus. Diabetes, 32, 101, 1983.
28. Malliani A., Pagani M., Lombardi F., Cerrutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation, 84, 482, 1991.
29. Ori Z., Monir G., Weiss J., Sayhouni X., Singer D.H. Heart rate variability. Frequence domain analysis. Cardiology Clinics, 10, 499, 1992.
30. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiology interpretation, and clinical use. Circulation, 93, 1043, 1996.